Literature DB >> 18178220

Peptide mimic of the HIV envelope gp120-gp41 interface.

Sunghwan Kim1, Hong-Bo Pang, Michael S Kay.   

Abstract

The human immunodeficiency virus envelope glycoprotein (Env) is composed of surface (gp120) and transmembrane (gp41) subunits, which are noncovalently associated on the viral surface. Human immunodeficiency virus Env mediates viral entry after undergoing a complex series of conformational changes induced by interaction with cellular CD4 and a chemokine coreceptor. These changes propagate from gp120 to gp41 via the gp120-gp41 interface, ultimately exposing gp41 and allowing it to form the trimer-of-hairpins structure that provides the driving force for membrane fusion. Key unresolved questions about the gp120-gp41 interface include the specific regions of gp41 and gp120 involved, the mechanism by which receptor and coreceptor-binding-induced conformational changes in gp120 are communicated to gp41, how trimer-of-hairpins formation is prevented in the prefusogenic gp120-gp41 complex, and, ultimately, the structure of the prefusion gp120-gp41 complex. Here, we develop a biochemical model system that mimics a key portion of the gp120-gp41 interface in the prefusogenic state. We find that a gp41 fragment containing the disulfide bond loop and C-peptide region binds primarily to the gp120 C5 region and that this interaction is incompatible with trimer-of-hairpins formation. Based on these data, we propose that in prefusogenic Env, gp120 sequesters the gp41 C-peptide region away from the N-trimer region, preventing trimer-of-hairpins formation until coreceptor binding disrupts this interface. This model system is a valuable tool for studying the gp120-gp41 complex, conformational changes induced by CD4 and coreceptor binding, and the mechanism of membrane fusion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18178220      PMCID: PMC2265733          DOI: 10.1016/j.jmb.2007.12.001

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  58 in total

1.  Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus.

Authors:  P D Kwong; R Wyatt; Q J Sattentau; J Sodroski; W A Hendrickson
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Protein design of an HIV-1 entry inhibitor.

Authors:  M J Root; M S Kay; P S Kim
Journal:  Science       Date:  2001-02-02       Impact factor: 47.728

3.  Energetics of the HIV gp120-CD4 binding reaction.

Authors:  D G Myszka; R W Sweet; P Hensley; M Brigham-Burke; P D Kwong; W A Hendrickson; R Wyatt; J Sodroski; M L Doyle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

4.  Sequential CD4-coreceptor interactions in human immunodeficiency virus type 1 Env function: soluble CD4 activates Env for coreceptor-dependent fusion and reveals blocking activities of antibodies against cryptic conserved epitopes on gp120.

Authors:  K Salzwedel; E D Smith; B Dey; E A Berger
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Interactions between HIV-1 gp41 core and detergents and their implications for membrane fusion.

Authors:  W Shu; H Ji; M Lu
Journal:  J Biol Chem       Date:  2000-01-21       Impact factor: 5.157

6.  Structure of a V3-containing HIV-1 gp120 core.

Authors:  Chih-chin Huang; Min Tang; Mei-Yun Zhang; Shahzad Majeed; Elizabeth Montabana; Robyn L Stanfield; Dimiter S Dimitrov; Bette Korber; Joseph Sodroski; Ian A Wilson; Richard Wyatt; Peter D Kwong
Journal:  Science       Date:  2005-11-11       Impact factor: 47.728

7.  The disulfide loop of gp41 is critical to the furin recognition site of HIV gp160.

Authors:  Jayita Sen; Amy Jacobs; Haiqing Jiang; Lijun Rong; Michael Caffrey
Journal:  Protein Sci       Date:  2007-06       Impact factor: 6.725

8.  Kinetic dependence to HIV-1 entry inhibition.

Authors:  H Kirby Steger; Michael J Root
Journal:  J Biol Chem       Date:  2006-06-27       Impact factor: 5.157

9.  A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.

Authors:  J M Binley; R W Sanders; B Clas; N Schuelke; A Master; Y Guo; F Kajumo; D J Anselma; P J Maddon; W C Olson; J P Moore
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

10.  Alanine scanning mutants of the HIV gp41 loop.

Authors:  Amy Jacobs; Jayita Sen; Lijun Rong; Michael Caffrey
Journal:  J Biol Chem       Date:  2005-05-24       Impact factor: 5.157

View more
  15 in total

1.  Resistance of human immunodeficiency virus type 1 to a third-generation fusion inhibitor requires multiple mutations in gp41 and is accompanied by a dramatic loss of gp41 function.

Authors:  Dirk Eggink; Ilja Bontjer; Johannes P M Langedijk; Ben Berkhout; Rogier W Sanders
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

2.  Characterization of the steric defense of the HIV-1 gp41 N-trimer region.

Authors:  Debra M Eckert; Yu Shi; Sunghwan Kim; Brett D Welch; Eunchai Kang; Emily S Poff; Michael S Kay
Journal:  Protein Sci       Date:  2008-09-18       Impact factor: 6.725

3.  Residues in the gp41 Ectodomain Regulate HIV-1 Envelope Glycoprotein Conformational Transitions Induced by gp120-Directed Inhibitors.

Authors:  Beatriz Pacheco; Nirmin Alsahafi; Olfa Debbeche; Jérémie Prévost; Shilei Ding; Jean-Philippe Chapleau; Alon Herschhorn; Navid Madani; Amy Princiotto; Bruno Melillo; Christopher Gu; Xin Zeng; Youdong Mao; Amos B Smith; Joseph Sodroski; Andrés Finzi
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

4.  A low-molecular-weight entry inhibitor of both CCR5- and CXCR4-tropic strains of human immunodeficiency virus type 1 targets a novel site on gp41.

Authors:  Edward J Murray; Daniel P Leaman; Nishant Pawa; Hannah Perkins; Chris Pickford; Manos Perros; Michael B Zwick; Scott L Butler
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

5.  In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1.

Authors:  Daniel P Leaman; Heather Kinkead; Michael B Zwick
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

6.  Membrane-anchored HIV-1 N-heptad repeat peptides are highly potent cell fusion inhibitors via an altered mode of action.

Authors:  Yael Wexler-Cohen; Yechiel Shai
Journal:  PLoS Pathog       Date:  2009-07-10       Impact factor: 6.823

7.  Novel ring structure in the gp41 trimer of human immunodeficiency virus type 1 that modulates sensitivity and resistance to broadly neutralizing antibodies.

Authors:  Sara M O'Rourke; Becky Schweighardt; William G Scott; Terri Wrin; Dora P A J Fonseca; Faruk Sinangil; Phillip W Berman
Journal:  J Virol       Date:  2009-05-27       Impact factor: 5.103

8.  Reduced genetic diversity in lymphoid and central nervous system tissues and selection-induced tissue-specific compartmentalization of neuropathogenic SIVsmmFGb during acute infection.

Authors:  Aaron B Reeve; Kalpana Patel; Nicholas C Pearce; Katherine V Augustus; Heber G Domingues; Shawn P O'Neil; Francis J Novembre
Journal:  AIDS Res Hum Retroviruses       Date:  2009-06       Impact factor: 2.205

9.  Asymmetric deactivation of HIV-1 gp41 following fusion inhibitor binding.

Authors:  Kristen M Kahle; H Kirby Steger; Michael J Root
Journal:  PLoS Pathog       Date:  2009-11-26       Impact factor: 6.823

Review 10.  Escape from human immunodeficiency virus type 1 (HIV-1) entry inhibitors.

Authors:  Christopher J De Feo; Carol D Weiss
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.